As of Apr 21
| +0.04 / +0.07%|
The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb have a median target of 56.50, with a high estimate of 68.00 and a low estimate of 40.00. The median estimate represents a +5.65% increase from the last price of 53.48.
The current consensus among 25 polled investment analysts is to Buy stock in Bristol-Myers Squibb. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.